Rephonic
Artwork for Decera Clinical Education Oncology Podcast

Decera Clinical Education Oncology Podcast

Decera Clinical Education
Chronic Lymphocytic Leukemia
BTK Inhibitors
Non-Small Cell Lung Cancer
Mantle Cell Lymphoma
Her3-Targeted Therapy
CAR T-Cell Therapy
Clinical Trials
Triangle Study
Pyrtobrutinib
SHINE Trial
NCCN Guidelines
ASCO Annual Meeting
Acute Myelogenous Leukemia
AML Treatment Regimens
Small Lymphocytic Lymphoma
Gold Standard Therapy
Myelofibrosis
Palliative Care
Oral Sirds
Oral Chemotherapy

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

PublishesTwice weeklyEpisodes223Founded5 years ago
Number of ListenersCategories
EducationCoursesMedicineHealth & Fitness

Listen to this Podcast

Artwork for Decera Clinical Education Oncology Podcast

Latest Episodes

In this podcast episode, Rami Komrokji, MD, reviews data from select presentations in myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) presented at the ASH 2025 Annual Meeting and shares expert perspectives on the clinical impl... more

YouTube

In this podcast episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Niels van de Donk, MD, PhD, address key questions on CELMoD agent therapy for multiple myeloma, including:

• Combination strategies

• Adverse event management

• Where CELMoD ... more

YouTube

In this episode, Dr John Heymach and Dr Solange Peters discuss key data presented at the IASLC World Conference on Lung Cancer including first-line maintenance in ES-SCLC (IMforte and DeLLphi-303 trials) and targeted treatment for NSCLC (FLAURA2, Bea... more

YouTube

In this episode, Shaji K. Kumar, MD, reviews key highlights from ASH 2025 in multiple myeloma (MM), focusing on emerging data for bispecific antibodies and CAR T-cell therapies across earlier and later lines of treatment. The discussion covers the fo... more

YouTube

Key Facts

Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

NEJM This Week
NEJM This WeekNEJM Group
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Dr. Rami Komrokji
Vice Chair of the Department of Malignant Neuropathology at Moffitt Cancer Center
Moffitt Cancer Center
Episode: PulseCast: Highlights in MDS/MPNs From the 2025 ASH Annual Meeting
Dr. Jeremy Abramson
Expert in lymphomas and CLL from Harvard Medical School and Mass General Brigham Cancer Center
Harvard Medical School and Mass General Brigham Cancer Center
Episode: PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
Dr. Hanny Al-Samkari
Physician at Massachusetts General Hospital, Harvard Medical School
Massachusetts General Hospital
Episode: PulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting
Amit Mahipal
Director of the Gastrointestinal Medical Oncology Program and Professor of Medicine
Case Western Reserve University
Episode: HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Shubham Pant
Professor of GI Medical Oncology and Director of Clinical Research at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Dr. Kelly Romo
Healthcare professional specializing in oncology at Blue Cross and Blue Shield of Michigan.
Blue Cross and Blue Shield of Michigan
Episode: Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Dr. Shauna Kraft
Pharmacist and academic at the University of Michigan College of Pharmacy.
University of Michigan
Episode: Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Eunice Wang
Oncologist from Roswell Park
Roswell Park Comprehensive Cancer Center
Episode: A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
Eytan Stein
Oncologist
Episode: A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?

Hosts

Mandy Murth
Host of the Decera Clinical Education Oncology Podcast
Amber Williams
Host of the Clinical Care Options Oncology Podcast
Tim Quill
Host of the Clinical Care Options Oncology Podcast

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Expert Highlights From the 2025 World Conference on Lung Cancer
Q: Dr. Peters, can you tell us about recent advances in non-small cell lung cancer?
Dr. Peters discusses advancements in targeted therapies for non-small cell lung cancer, emphasizing the importance of precision oncology and the development of effective treatments for previously 'undruggable' mutations such as KRAS and HER2.
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Q: If a patient is not tolerating one of the CDK46 inhibitors, what does your approach look like?
If there's no evidence of disease progression, I prefer switching to an alternative CDK46 inhibitor instead of moving on to the next line of treatment.
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Q: What are some of the clinical or treatment-related outcomes that you're looking at that guide the decision for which CDK46 inhibitor to use?
The decision involves considering overall survival benefits, side effect profiles, and the patient's expressed goals for treatment.
Current Considerations for Adverse Event Management With HER3-Directed Agents
Q: What is one thing that you would like community practitioners to know about HER3-targeted therapy?
There is currently no HER3-targeted therapy or ADC that is approved, but it's an exciting time with new drugs showing promising efficacy signals.
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Q: What are you going to do in your practice with the cervical cancer data?
Dr. Fujiwara indicated he would likely use the interlaced regimen, probably in combination with PEMBRO, once the A18 result is approved for regulatory agents.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

Focused on enhancing the understanding of oncology practices, the content provides professionals in the healthcare field with updates on emerging data and best practices concerning various forms of cancer. Episodes feature expert discussions that explore breakthroughs in treatments, clinical trials, and methodologies that can directly impact patient care across a range of malignancies, including solid tumors and hematological disorders. Noteworthy is the opportunity for listeners to earn CME/CE credits through selected episodes, making it particularly attractive for clinicians looking to stay current in their field while gaining continuing education credits.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Oncology Today with Dr Neil Love
2. NEJM This Week
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. ASCO Daily News
5. ASCO Guidelines

How many episodes of this podcast are there?

this podcast launched 5 years ago and published 223 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Dr. Rami Komrokji
2. Dr. Jeremy Abramson
3. Dr. Hanny Al-Samkari
4. Amit Mahipal
5. Shubham Pant
6. Dr. Kelly Romo
7. Dr. Shauna Kraft
8. Eunice Wang

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days